Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation

   Life Technologies Launches New Bioinformatics Software Platform Enabling
      Bio-Design and Gene Synthesis from Next Generation Sequencing Data

Vector NTI® Express Designer Bioinformatics Software Streamlines Sequence
Analysis, Design and Ordering

PR Newswire

CARLSBAD, Calif., April 11, 2013

CARLSBAD, Calif., April 11, 2013 /PRNewswire/ --Life Technologies Corporation
(NASDAQ: LIFE) today announced the launch of Vector NTI® Express Designer, the
latest advancement in its Vector NTI® software platform, which offers
researchers comprehensive and streamlined custom vector and genetic construct
design and synthesis. The desktop software tool is designed for molecular
biology, metabolic engineering, genetic engineering, and synthetic biology
professionals who want to rationally design, assemble and order synthetic
genetic "parts," optimizing genetic components for a broad range of
applications.

An extension of the Vector NTI® software offerings, Express Designer
incorporates an integrated gene synthesis service for rapid sequence
submission and order placement, effectively building a bridge from DNA
sequence to gene synthesis. Customers can use the Express Designer software
tools to design custom DNA parts and submit them directly to Life
Technologies' GeneArt® portal for synthesis.

"Molecular and synthetic biologists can now move from construct design to
synthesis faster than ever before," said Nathan Wood, General Manager and Vice
President of Synthetic Biology at Life Technologies. "This launch represents a
true game changer in the ease, speed and accuracy with which investigators
can design and order DNA customized to their needs, as well as the increased
confidence they can have that constructs will perform successfully in their
experiments."

Vector NTI® Express Designer also provides sequence optimization to fine tune
expression levels of cloned genes, enables construction of multiple vectors
for compatible and simultaneous function, and generates variants from template
DNA parts, devices, and circuits more effectively. In addition to designing
and ordering custom components, the software also contains an electronic
database or "mini electronic lab notebook" that allows researchers to maintain
a searchable record of genetic parts, constructs and experimental results that
can be referred to and utilized to optimize constructs and circuits.

"The Vector NTI Express Designer will allow us to tackle difficult design
challenges in synthetic biology," said Christopher Voigt, Ph.D., associate
professor of Biological Engineering at M.I.T. "The software automates and
facilitates the design process with an intuitive graphical-user interface
where well-characterized and annotated parts can be drag-and-dropped to create
standard devices and advanced circuits." Voigt is a leader in the study of
circuit design underlying the development of synthetic organisms, a process
that requires constructing synthetic multi-gene pathways.

"The power of the Vector NTI Express Designer database is that it allows us to
track and analyze our experimental results so that we avoid duplicating effort
and focus on getting to the answer more quickly," said Steve Mayfield, Ph.D.,
professor in the Division of Biological Sciences at the University of
California, San Diego. "We can focus more on what we want our constructs to do
and less on how to make them do it." Mayfield is a pioneer in the genetic
design of organisms such as algae for biofuel production.

Vector NTI® Express Designer is built on a the Vector NTI® Sequence Analysis
and Bioinformatic Tools platform, and so inherits many of the applications
associated with that platform, including: sequence analysis and design,
annotation, and illustration; molecular biology data management; open reading
frame and restriction enzyme analysis and mapping; primer design; recombinant
molecule design, including Gateway® and TOPO® cloning, GeneArt® seamless
cloning & high-order assembly and gene synthesis.

Built on the trusted history of high-quality sequence analysis and design
tools of Vector NTI® Software, Vector NTI® Express Designer enables rational
bio-design on the most popular computing architectures, including native Mac
OSX 10.6+, Windows XP, Windows 7, and Windows 8 operating systems. Its plug-in
architecture allows users to have confidence that additional features and
functionality can be added to the platform and deliver more value over time
while its Automatic Updater ensures that users will be automatically notified
of updates and given the option to download new or updated plug-ins to always
be running the latest, most complete software package available.

For more information, please visit http://www.lifetechnologies.com/vectornti.

All products referenced are for Research Use Only. Not intended for diagnostic
uses.

About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology
company that is committed to providing the most innovative products and
services to leading customers in the fields of scientific research, genetic
analysis and applied sciences. With a presence in more than 180 countries, the
company's portfolio of 50,000 end-to-end solutions is secured by more than
5,000 patents and licenses that span the entire biological spectrum --
scientific exploration, molecular diagnostics, 21^stcentury forensics,
regenerative medicine and agricultural research. Life Technologies has
approximately 10,000 employees and had sales of $3.8 billion in 2012.

Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about Life
Technologies' anticipated results that involve risks and uncertainties. Some
of the information contained in this press release, including, but not limited
to, statements as to industry trends and Life Technologies' plans, objectives,
expectations and strategy for its business, contains forward-looking
statements that are subject to risks and uncertainties that could cause actual
results or events to differ materially from those expressed or implied by such
forward-looking statements. Any statements that are not statements of
historical fact are forward-looking statements. When used, the words
"believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and
the like, and/or future tense or conditional constructions ("will," "may,"
"could," "should," etc.), or similar expressions, identify certain of these
forward-looking statements. Important factors which could cause actual results
to differ materially from those in the forward-looking statements are detailed
in filings made byLife Technologies with the Securities and Exchange
Commission.Life Technologies undertakes no obligation to update or revise any
such forward-looking statements to reflect subsequent events or circumstances.

(Logo: http://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

Life Technologies Contact
Suzanne Clancy
760-602-4545
858-205-4235 (mobile)
suzanne.clancy@lifetech.com

SOURCE Life Technologies Corporation

Website: http://www.lifetechnologies.com/